Yuzhuo Pan - Concepedia

Author

Yuzhuo Pan

United States Food and Drug Administration

Also Known As

Ming Che, Pan, Yuzhuo, Yu-Zhuo Pan, Yu-zhuo Pan, Yuzhuo Pan, Yu‐Zhuo Pan

Publications

1.1K

Citations

H-Index

Concepts

All Affiliations

United States Food and Drug Administration Center for Drug Evaluation and Research Jilin University University at Buffalo, State University of New York First Hospital of Jilin University

About

Yuzhuo Pan is an author at United States Food and Drug Administration specializing in medicine, pharmacology, and physiologically based pharmacokinetics.

Top Concepts

#	Concept	H-Index	Publications	Citations
1	Medicine	7	7	552
2	Biochemistry	2	2	161
3	Health Sciences	1	1	182
4	Natural Sciences	1	1	75
5	Cell Biology	1	1	75

Yuzhuo Pan

Publications

886

Citations

H-Index

Page 1

	Year	Citations
FDA Approval: Ceritinib for the Treatment of Metastatic Anaplastic Lymphoma Kinase–Positive Non–Small Cell Lung Cancer Sean Khozin, Gideon M. Blumenthal, Lijun Zhang, Clinical Cancer Research PathologyFda ApprovalPharmacotherapyPre-clinical PharmacologyMeaningful Orr	2015	182
miRdSNP: a database of disease-associated SNPs and microRNA target sites on 3'UTRs of human genes Andrew E. Bruno, Li Li, James Kalabus, BMC Genomics	2012	169
Predicting the Effect of Cytochrome P450 Inhibitors on Substrate Drugs: Analysis of Physiologically Based Pharmacokinetic Modeling Submissions to the US Food and Drug Administration Christian Wagner, Yuzhuo Pan, Vicky Hsu, Clinical Pharmacokinetics Cytochrome P450 InhibitorsPhysiologically Based PharmacokineticsPharmacokinetic ModelingBiochemistrySubstrate Drugs	2014	143
Predicting the Effect of CYP3A Inducers on the Pharmacokinetics of Substrate Drugs Using Physiologically Based Pharmacokinetic (PBPK) Modeling: An Analysis of PBPK Submissions to the US FDA Christian Wagner, Yuzhuo Pan, Vicky Hsu, Clinical Pharmacokinetics Physiologically Based PharmacokineticsPharmacokinetic ModelingCyp3a InducersPbpk SubmissionsPharmacology	2015	93
Noncoding microRNAs: small RNAs play a big role in regulation of ADME? Ai‐Ming Yu, Yuzhuo Pan Acta Pharmaceutica Sinica B Small Rnas PlaySystems BiologyMedicineNatural SciencesAdme Genes	2012	75
<scp>MicroRNA</scp> expression is differentially altered by xenobiotic drugs in different human cell lines Alice Cristina Rodrigues, Xin Li, Laura Radecki, Biopharmaceutics & Drug Disposition	2011	54
Haptoglobin‐β chain defined by monoclonal antibody RM2 as a novel serum marker for prostate cancer Seiichi Saito, Yasuko Murayama, Yuzhuo Pan, International Journal of Cancer Glycoprotein Rm2UrologyGenitourinary CancerMedicineImmunology	2008	29
Application of surface-enhanced laser desorption/ionization time-of-flight-based serum proteomic array technique for the early diagnosis of prostate cancer Yuzhuo Pan, Xueyuan Xiao, Dan Zhao, Asian Journal of Andrology	2006	27
Mass screening of prostate cancer in a Chinese population: the relationship between pathological features of prostate cancer and serum prostate specific antigen Hongwen Gao, Yulin Li, Shan Wu, Asian Journal of Andrology	2005	25
FDA approval summary: fam-trastuzumab deruxtecan-nxki for unresectable or metastatic non-small cell lung cancer with activating <i>HER2</i> mutations Gautam U. Mehta, Paz J. Vellanki, Yi Ren, The Oncologist	2024	21

Page 1